Medications

Paxlovid soon will not be free for Americans

The antiviral Paxlovid has kept patients from becoming severely ill and dying from COVID-19 since it became available—at no cost to them. But by the middle of next year, the U.S. government will stop subsidizing the medication. ...

Alzheimer's disease & dementia

Controversial Alzheimer's drug approval sparks surprising impact

When the U.S. Food and Drug Administration gave controversial accelerated approval to the first Alzheimer's drug in nearly 20 years, it had a surprising impact on attitudes about research into the disease. A survey by University ...

Medications

New ALS drug approved in Canada while still under FDA review

An experimental drug for the neurological disorder ALS was approved in Canada on Monday, but an ongoing evaluation of the treatment by the U.S. Food and Drug Administration has raised questions about its effectiveness.

page 2 from 11